These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
360 related items for PubMed ID: 19540231
21. Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin. Kricker JA, Hyde CE, Van Lonkhuyzen DR, Hollier BG, Shooter GK, Leavesley DI, Herington AC, Upton Z. Growth Factors; 2010 Oct; 28(5):359-69. PubMed ID: 20569097 [Abstract] [Full Text] [Related]
23. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM. Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012 [Abstract] [Full Text] [Related]
24. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Arai T, Busby W, Clemmons DR. Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319 [Abstract] [Full Text] [Related]
29. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. Proc Natl Acad Sci U S A; 2006 Aug 29; 103(35):13028-33. PubMed ID: 16924115 [Abstract] [Full Text] [Related]
30. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Hollier BG, Kricker JA, Van Lonkhuyzen DR, Leavesley DI, Upton Z. Endocrinology; 2008 Mar 29; 149(3):1075-90. PubMed ID: 18079201 [Abstract] [Full Text] [Related]